Dr. Ted Lithgow Appointed to Healthcare Compliance Packaging Council Board of Directors

The Healthcare Compliance Packaging Council (HCPC) recently appointed Dr. Ted Lithgow, chief science officer, Healthcare, for MeadWestvaco Corporation (NYSE: MWV) to its Board of Directors. Dr. Lithgow’s appointment begins immediately and runs through 2012.

"HCPC serves an important role as an advocate for improving patient adherence to medicines through packaging, and I am pleased to serve on HCPC’s board with so many distinguished members of the adherence packaging community,” says Dr. Lithgow. "I look forward to working more closely with HCPC and to contributing to the organization.”

HCPC's Board of Directors is responsible for providing direction and identifying strategies to elevate packaging as a means for improving patient compliance to medications. The organization is primarily comprised of pharmaceutical packaging materials suppliers, machinery suppliers, and contract packagers. For more than 20 years, the organization has promoted the many benefits of adherence packaging to all channels within the pharmaceutical supply chain, including physicians and payors. In this environment of Health Reform, the HCPC sees the opportunity to make a significant contribution to improving health outcomes through better packaging.

Dr. Lithgow is the scientific and commercial lead for MWV's healthcare business. He is responsible for setting direction, and facilitating commercial strategy and implementation for all MWV adherence products targeted for pharmaceutical and retail customers, and for healthcare professionals.

Prior to joining MWV, Dr. Lithgow served as senior commercial lead and representative of global prescription pharmaceutical (GPB) development programs, with additional responsibility for all cross-customer and divisional initiatives and processes at Schering-Plough. He was a member of the Global Business Management Team, the corporation’s Research Leadership Committee, the Exploratory Development Committee, and Pharmaceutical Leadership Board governing bodies. Prior to Schering-Plough, Dr. Lithgow served as president of commercial operations and emerging technologies at Pharmacia Corporation, director of new products marketing, global CNS, psychiatry and neurology at Wyeth Corporation and previous director, US women’s health care, prescription therapeutics, contraception, and reproductive disorders. Dr. Lithgow's extensive OTC experience includes R&D project management, and brand management for Zantac 75, Lubriderm Lotion, Neosporin First Aid, and Rolaids.

About HCPC

The Healthcare Compliance Packaging Council is a not-for-profit trade association whose mission is to promote the greater use of compliance prompting packaging to improve patient adherence and patient outcomes. For more information on HCPC, please visit our website, www.hcpconline.org.

About MWV

MeadWestvaco Corporation (NYSE: MWV) provides packaging solutions to many of the world’s most-admired brands in the healthcare, beauty and personal care, food, food service, beverage, home and garden, and tobacco industries. The company's businesses also include Consumer & Office Products, Specialty Chemicals, and the Community Development and Land Management Group, which sustainably manages the company’s land holdings to support its operations, and to provide for conservation, recreation and development opportunities. With 17,500 employees worldwide, MWV operates in 30 countries and serves customers in more than 100 nations. MWV manages all of its forestlands in accordance with internationally recognized forest certification standards, and has been named to the Dow Jones Sustainability World Index for seven consecutive years. For more information, please visit www.mwv.com.